Back to top
more

Hologic (HOLX)

(Delayed Data from NSDQ)

$79.29 USD

79.29
1,466,257

-1.20 (-1.49%)

Updated Nov 7, 2024 03:59 PM ET

After-Market: $79.32 +0.03 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 251)

Industry: Medical - Instruments

Zacks News

Masimo (MASI) Launches Root Platform with Kite Trademark

Irvine, CA-based Masimo Corporation (MASI) announced full market release of the Root monitoring platform with a Kite trademark (a supplementary display system).

    AngioDynamics (ANGO) Prices 2.5M Secondary Share Offering

    AngioDynamics, Inc. (ANGO) announced that it has priced its underwritten public offering of 2.35 million shares of common stock.

      ABIOMED (ABMD) Banks on Impella Platform, Forex a Concern

      On Apr 7, we issued an updated research report on Danvers, MA-based ABIOMED, Inc. (ABMD), a leading medical product developer.

        Hill-Rom's Innovations Make Surgeries More Safe, Accurate

        Hill-Rom Holdings, Inc. (HRC) recently demonstrated the impact of surgical patient positioning on skin and nerve pressure-related injuries.

          PetMed Faces Concerns over New Order Sales, Competition

          On Apr 6, we issued an updated research report on Pompano Beach, FL-based PetMed Express, Inc. (PETS).

            athenahealth Now a Strong Buy: Should You Add the Stock?

            On Apr 5, athenahealth (ATHN) was raised to a Zacks Rank #1 (Strong Buy).

              Medidata & TESARO Win CARE 'Clinical Partnership' Award

              Medidata Solutions Inc. (MDSO) recently announced the receipt of the 'Clinical Partnership of the Year' award at the second annual Clinical and Research Excellence (CARE) Awards, courtesy of its 'unique technology collaboration' with TESARO.

                Omnicell's Aesynt Buyout Looks Promising amid Several Woes

                On Apr 6, we issued an updated research report on Mountain View, CA-based Omnicell Inc. (OMCL).

                  David Bartosiak headshot

                  Crude Bucks Choppy Trend - Dave's Daily Dive

                  Crude bucked the choppy trend in markets today as equities sloshed back-and-forth most of the day

                    Tirthankar Chakraborty headshot

                    New Strong Buy Stocks for April 4th

                    Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday

                      Hologic Completes Cynosure Buyout, Boosts Core Business

                      Hologic, Inc. (HOLX) recently announced the completion of it earlier declared acquisition of marketer of aesthetic treatment systems, Cynosure, Inc.

                        Cynosure (CYNO) to be Acquired by Hologic in $1.65B Deal

                        Cynosure, Inc. (CYNO), announced that it has entered into a definitive merger agreement with Hologic, Inc. (HOLX).

                          Hologic (HOLX) Beats on Q1 Earnings, Lowers '17 Guidance

                          Hologic Inc. (HOLX) reported first-quarter fiscal 2017 adjusted earnings per share (EPS) of 52 cents, up 13% year over year.

                            Medical Instrument Stocks' Earnings on Feb 1: EW, HOLX, BABY

                            Already more than one-third of the S&P 500 members (170 companies making up for 19.2% of the total market cap) have reported their Oct--Dec 2016 quarter's earnings results.

                              John Blank headshot

                              4 Good Reasons to Focus on the USA: Global Week Ahead

                              In the Global Week Ahead, the bulk of any trader???s time should focus on the good ol' USA. Why do we think that? There are four old-fashioned reasons.

                                Abiomed (ABMD) Beats Earnings & Revenue Estimates in Q3

                                Abiomed Inc. (ABMD) reported third-quarter fiscal 2017 earnings of 34 cents per share, which surpassed the Zacks Consensus Estimate by 5 cents and surged 47.8% from the year-ago quarter.

                                  C.R. Bard (BCR) Q4 Earnings & Sales Better Than Expected

                                  C.R. Bard Inc. (BCR) reported adjusted earnings of $2.77 in the fourth quarter of 2016, exceeding the Zacks Consensus Estimate by 4 cents and improving from the year-ago quarterly number of $2.43.

                                    Quality Systems (QSII) Beats on Earnings & Revenues in Q3

                                    Irvine, CA-based Quality Systems Inc. (QSII) reported third-quarter fiscal 2017 adjusted earnings of 21 cents per share, exceeding the Zacks Consensus Estimate of 18 cents.

                                      Varian Medical (VAR) Misses on Q1 Earnings and Revenues

                                      Varian Medical Systems, Inc. (VAR) reported adjusted earnings of 75 cents per share in the first quarter of fiscal 2017.

                                        McKesson (MCK) Beats on Earnings in Q3, Inks Buyout Deal

                                        McKesson Corporation (MCK) reported third-quarter fiscal 2017 earnings of $3.03 per share, beating the Zacks Consensus Estimate of $2.95 but declining from the year-ago figure of $3.18.

                                          Stryker (SYK) Beats Q4 Earnings, Provides FY17 Guidance

                                          Maintaining its streak of positive earnings surprises, Stryker Corp (SYK) reported adjusted earnings of $1.78 per share in the fourth quarter of 2016, which comfortably beat the Zacks Consensus Estimate by 2 cents.

                                            Intuitive Surgical (ISRG) Beats on Q4 Earnings & Revenues

                                            Intuitive Surgical Inc. (ISRG) posted adjusted earnings of $5.30 per share in the fourth quarter of 2016, beating the Zacks Consensus Estimate by four cents.

                                              Is a Surprise in Store for Hologic (HOLX) in Q1 Earnings?

                                              Hologic Inc. (HOLX) is slated to report first-quarter fiscal 2017 financial results on Feb 1, after the closing bell.

                                                The Zacks Analyst Blog Highlights: Intuitive Surgical, Stryker and Hologic

                                                The Zacks Analyst Blog Highlights: Intuitive Surgical, Stryker and Hologic

                                                  3 Medical Device Stocks Likely to Beat Earnings Estimates

                                                  The likely revocation of the 2.3% medical device excise tax is going to be a big bonus for both the behemoths and small players.